December 06, 2019
Oncopeptides will host a webcast on Tuesday, December 10[th] at 13:00 (CET) to provide an update regarding data presented at the ASH annual meeting
Media
December 04, 2019
Nordic Nanovector: New preclinical data offer insights into enhancing Betalutin®-based therapies in NHL
December 02, 2019
Oncopeptides appoints Joseph Horvat as President North America
December 02, 2019
Orexo appoints Dennis Urbaniak as Executive Vice President Digital Health
November 27, 2019
Orexo acquires exclusive US rights to commercialize vorvida®, a digital therapy for alcohol use disorder with scientifically proven efficacy
November 19, 2019
Interim Report Q3 2019
November 19, 2019
Nordic Nanovector ASA – Results for the Third Quarter 2019
November 18, 2019
Strongbridge Biopharma plc Announces Additional Steps to Improve Operational Efficiencies and Appoints New Lead Independent Director
November 13, 2019
Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
November 13, 2019
Vicore Pharma has completed a directed share issue of approximately SEK 125 million